Morphochem and The Genetics Company announce the resolution of the X-ray structure of beta-secretase with a novel inhibitor

06-Jul-2005

The Genetics Company, Inc. and Morphochem AG have announced that they have successfully achieved an important milestone in their research collaboration using Morphochem's structural biology tools to support the beta-secretase program of The Genetics Company.

Morphochem applied its protein expression, purification, crystallization and structure determination capabilities, all part of Morphochem's MOREsystem®, to generate biostructural information for further optimization of inhibitor compounds against beta-secretase identified by The Genetics Company as potential new therapeutic agents for Alzheimer's Disease.

Other news from the department science

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance